Low-dose aprotinin infusion is not clinically useful to reduce bleeding and transfusion of homologous blood products in high-risk cardiac surgical patients
Jean‐François Hardy(Université de Montréal), Danielle Robitaille(Université de Montréal), Jean Desroches(Université de Montréal), Sylvain Bélisle, Jean Perrault(Mayo Clinic in Arizona), Michel Carrier(Montreal Heart Institute)
Cited by 36
Related Papers
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
|JNCI Journal of the National Cancer Institute|1997|986
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study
|The Journal of Pediatrics|2003|614
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management
|Canadian Journal of Anesthesia/Journal canadien d anesthésie|2006|293
Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement.
|PubMed|2019|232
Massive transfusion and coagulopathy: pathophysiology and implications for clinical management
|Canadian Journal of Anesthesia/Journal canadien d anesthésie|2004|229